Management of Children with Multiple Sclerosis
US Neurology, 2017;13(1):42–6 DOI: https://doi.org/10.17925/USN.2017.13.01.42
Advances in Pulmonary Care in Duchenne Muscular Dystrophy
US Neurology, 2017;13(1):35–41 DOI: https://doi.org/10.17925/USN.2017.13.01.35
Optimizing the Use of Outcome Measures in Chronic Inflammatory Demyelinating Polyneuropathy
US Neurology, 2017;13(1):26–34 DOI: https://doi.org/10.17925/USN.2017.13.01.26
Interneuronal Transfer and Distal Action of Tetanus Toxin and Botulinum Neurotoxins A and D in Central Neurons
US Neurology, 2017;10(1):16–7 DOI: https://doi.org/10.17925/USN.2017.13.01.16
US Neurology, 2016;12(1):34–8 DOI: http://doi.org/10.17925/USN.2016.12.01.34
Leading experts on the management of chronic inflammatory demyelinating polyneuropathy (CIDP) discuss outcome measures, and how a composite score incorporating multiple assessments may be developed...
The video features personal stories of individuals with multiple sclerosis who have benefitted from MSAA’s programs and services. Below is a link to our web page that explains a bit more: http://...
Professor Said Beydoun, from the Keck Medical Center of University of Southern California, discusses the potential pitfalls to watch out for when making a diagnosis of CIDP. This interview is...
Jean-Marc Leger reviews the advantages of plasma exchange over current therapeutic options in chronic inflammatory demyelinating polyneuropathy (CIDP) and Guillain-Barré syndrome (GBS). This...
Cathy Chester interviews Dr. Mary Ann Picone on the relationship between vitamin D and interferon beta-1b in the treatment of multiple sclerosis. This interview is related to an Insight article...
The touchNEUROLOGY website provides a selection of resources to inform clinicians and patients about the latest developments in the field. The following are quick, non peer-reviewed, opinion-based updates addressing current trends and opinion on the most recent advances in the area of neurology: